Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 25, 2026

Hercules Capital (HTGC) Faces Securities Class Action After Short Seller Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman

View original at globenewswire.com
Hercules Capital (HTGC) Faces Securities Class Action After Short Seller Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman SAN FRANCISCO, March 25, 2026 (GLOBE NEWSWIRE) -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchas…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Despite billions worth of software debt across the industry falling into distressed territory, Hercules still marks its software book at 100 cents on the dollar

    60% confidence
  • About 35% of the value of Hercules' loan portfolio is software-exposed

    60% confidence
  • Hercules' finance team was small and overstretched with few checks in place compared to other BDCs

    60% confidence
  • A growing share of Hercules' income is phantom because of the company's increasing usage of payment-in-kind loans

    60% confidence
  • Hercules overstated the due diligence with which it conducted its deal sourcing and loan origination process, overstated the due diligence in its portfolio valuation process, and reported misclassified portfolio investments

    60% confidence
  • Hercules' deal sourcing process essentially amounted to going on the website for Google Ventures and just seeing what they invest in and copying it

    60% confidence
  • Hercules has assured investors about the robust origination process for sourcing potential investments and the effectiveness of its due diligence process

    60% confidence
  • Investigating whether Hercules misled investors about its sourcing, underwriting, marks, PIKs, and ultimately its NAV

    60% confidence
  • Hercules overstated or misrepresented its portfolio valuations and its net asset value

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com